DEVELOPMENT OF A NOVEL DRUG-RELEASE SYSTEM, TIME-CONTROLLED EXPLOSION SYSTEM (TES) .1. CONCEPT AND DESIGN

被引:78
|
作者
UEDA, S [1 ]
HATA, T [1 ]
ASAKURA, S [1 ]
YAMAGUCHI, H [1 ]
KOTANI, M [1 ]
UEDA, Y [1 ]
机构
[1] FUJISAWA PHARMACEUT CO LTD,TECHNOL DEV LABS,YODOGAWA KU,OSAKA 532,JAPAN
关键词
CONTROLLED DRUG RELEASE SYSTEM; DRUG RELEASE; LAG TIME; MEMBRANE DESTRUCTION; METOPROLOL; TIME-CONTROLLED EXPLOSION SYSTEM (TES);
D O I
10.3109/10611869409015891
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A novel controlled drug release system. Time-Controlled Explosion System (TES) has been developed. TES has a four-layered spherical structure, which consists of core, drug, swelling agent and water insoluble polymer membrane. TES is characterized by a rapid drug release with a precisely programmed lag time; i.e. expansion of the swelling agent by water penetrating through the outer membrane, destruction of the membrane by stress due to swelling force and subsequent rapid drug release. For establishing the concept and development strategy, TES was designed using metoprolol and polystyrene balls (size: 3.2 mm in diameter) as a model drug and core particles. Among the polymers screened, low-substituted hydroxypropylcellulose (L-HPC) and ethylcellulose (EC) were selected for a swelling agent and an outer water insoluble membrane, respectively. The release profiles of metoprolol from the system were not affected by the pH of the dissolution media. Lag time was controlled by the thickness of the outer EC membrane; thus, a combination of TES particles possessing different lag times could offer any desired release profile of the model compound, metoprolol.
引用
收藏
页码:35 / 44
页数:10
相关论文
共 50 条
  • [31] Development of a Novel Controlled-Release System for Gastric Retention
    Arati A. Deshpande
    Navnit H. Shah
    Christopher T. Rhodes
    Waseem Malick
    Pharmaceutical Research, 1997, 14 : 815 - 819
  • [32] Development of a novel controlled-release system for gastric retention
    Deshpande, AA
    Shah, NH
    Rhodes, CT
    Malick, W
    PHARMACEUTICAL RESEARCH, 1997, 14 (06) : 815 - 819
  • [33] DESIGN AND INVITRO EVALUATION OF A CONTROLLED RELEASE DRUG DELIVERY SYSTEM OF SULFASOMIDINE
    DAS, SK
    GUPTA, BK
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1985, 11 (08) : 1621 - 1638
  • [34] DRUG-RELEASE BEHAVIOR IN GASTROINTESTINAL-TRACT OF BEAGLE DOGS FROM MULTIPLE-UNIT TYPE RATE-CONTROLLED OR TIME-CONTROLLED RELEASE PREPARATIONS COATED WITH INSOLUBLE POLYMER-BASED FILM
    NARISAWA, S
    NAGATA, M
    ITO, T
    YOSHINO, H
    HIRAKAWA, Y
    NODA, K
    JOURNAL OF CONTROLLED RELEASE, 1995, 33 (02) : 253 - 260
  • [35] Development Of A Controlled Drug Release System Of Cripto For Muscular Dystrophies Therapy
    Lev, R.
    Kossover, O.
    Lati, Y.
    Seliktar, D.
    TISSUE ENGINEERING PART A, 2016, 22 : S137 - S137
  • [36] Quality by Design Empowered Development and Optimisation of Time-Controlled Pulsatile Release Platform Formulation Employing Compression Coating Technology
    Patadia, Riddhish
    Vora, Chintan
    Mittal, Karan
    Mashru, Rajashree C.
    AAPS PHARMSCITECH, 2017, 18 (04): : 1213 - 1227
  • [37] Quality by Design Empowered Development and Optimisation of Time-Controlled Pulsatile Release Platform Formulation Employing Compression Coating Technology
    Riddhish Patadia
    Chintan Vora
    Karan Mittal
    Rajashree C. Mashru
    AAPS PharmSciTech, 2017, 18 (4) : 1213 - 1227
  • [38] Impedance controlled master-slave manipulation system. Part 1. Basic concept and application to the system with a time delay
    Tachi, Susumu
    Sakaki, Taisuke
    Advanced Robotics, 1992, 6 (04) : 483 - 503
  • [39] Design and evaluation of mucoadhesive beads of glipizide as a controlled release drug delivery system
    Bera, K.
    Khanam, J.
    Mohanraj, K. P.
    Mazumder, B.
    JOURNAL OF MICROENCAPSULATION, 2014, 31 (03) : 220 - 229
  • [40] A novel thermo-responsive drug delivery system with positive controlled release
    Zhang, XZ
    Zhuo, RX
    Cui, JZ
    Zhang, JT
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 235 (1-2) : 43 - 50